Publications & Works

Published journal articles indexed by SCI, SSCI, and AHCI
Articles Published in Other Journals
Refereed Congress / Symposium Publications in Proceedings

MEME KANSERİNDE ATİPİK PREZENTASYON, OLGU SUNUMU

26-30 NİSAN 2023 10. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Turkey, 26 - 30 April 2023

MEME KANSERİNDE NADİR BİR PARANEOPLASTİK SENDROM, OLGU SUNUMU

26-30 NİSAN 2023 10. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Ankara, Turkey, 26 - 30 April 2023

BRCA MUTASYONLU HASTALARIN KLİNİKOPATOLOJİK ÖZELLİKLERİ

8. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Antalya, Turkey, 3 - 07 November 2021, no.187, pp.112 Sustainable Development

Geç tanı alan bir melanom olgusu

13-17 EKİM 2021 5. ULUSAL İMMÜNOTERAPİ VE ONKOLOJİ KONGRESİ, Antalya, Turkey, 13 - 17 October 2021

Geç tanı alan bir melanom olgusu

5. Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Turkey, 13 - 17 October 2021, pp.10-11 Creative Commons License

Dabrafenib+trametinibe bağlı grade 4 nötropeni olgusu

5. Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Turkey, 13 - 17 October 2021, pp.20

Perioperative FLOT: Tolerability, pathological response rates, and the role of adjuvant phase

ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 July 2020, vol.31 identifier

The effect of chemotherapy on survival applied in the last term of life in cancer patients

10th Eurasian Hematology Oncology Congress, İstanbul, Turkey, 8 - 11 October 2019, vol.85 Sustainable Development identifier

Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2019, vol.37 Sustainable Development identifier

Erken evre Seminom’xxda Radyoterap mi, Kemoterapi mi?

2. Ulusal Ürogenital Kanserler Kongresi, Turkey, 11 - 14 October 2018

Metastatik Renal Hücreli Karsinom Tek Merkez Deneyimi

2. Ulusal Ürogenital Kanserler Kongresi, Turkey, 11 - 14 October 2018

PRİMER İNCE BARSAK MALİGN MELANOM OLGUSU

7. TÜRK TIBBİ ONKOLOJİ KONGRESİ, Turkey, 21 - 25 March 2018

COMPARISON OF SECOND LINE TREATMENT OUTCOMES BETWEEN SENSITIVE AND REFRACTORY SMALL CELL LUNG CANCER PATIENTS: A RETROSPECTIVE ANALYSIS

37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 28 September - 02 October 2012, vol.23, pp.497-498 Sustainable Development identifier

Pulmonary toxicity in patients receiving docetaxel chemotherapy

45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 29 May - 02 June 2009, vol.27 identifier

The prognostic impact of body mass index (BMI) in early breast cancer (BC) patients (pts).

41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23 Sustainable Development identifier
Metrics

Publication

104

Citation (WoS)

520

H-Index (WoS)

14

Citation (Scopus)

550

H-Index (Scopus)

15

H-Index (Scholar)

18

Project

5

Open Access

10
UN Sustainable Development Goals